LAT1

Advertisement

cGxPJobs Banner

Telix Doses First Patient in Phase 3 Glioblastoma Trial

Melbourne, Australia & Indianapolis, Indiana, U.S. | April 15, 2026 Telix Pharmaceuticals has announced a major clinical milestone with...

By cGxPwire Editor
April 15, 2026

Read More

Advertisement

cGxPJobs

Directory